Fsd Pharma Class Stock Shares Outstanding
| HUGE Stock | USD 0.46 0.04 8.00% |
FSD Pharma Class fundamentals help investors to digest information that contributes to FSD Pharma's financial success or failures. It also enables traders to predict the movement of FSD Stock. The fundamental analysis module provides a way to measure FSD Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FSD Pharma stock.
The current year's Common Stock Shares Outstanding is expected to grow to about 41.6 M. FSD | Shares Outstanding |
FSD Pharma Class Company Shares Outstanding Analysis
FSD Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current FSD Pharma Shares Outstanding | 40.43 M |
Most of FSD Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FSD Pharma Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
FSD Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for FSD Pharma is extremely important. It helps to project a fair market value of FSD Stock properly, considering its historical fundamentals such as Shares Outstanding. Since FSD Pharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of FSD Pharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of FSD Pharma's interrelated accounts and indicators.
Click cells to compare fundamentals
FSD Shares Outstanding Historical Pattern
Today, most investors in FSD Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various FSD Pharma's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of FSD Pharma shares outstanding as a starting point in their analysis.
FSD Pharma Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
FSD Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, FSD Pharma Class has 40.43 M of shares currently outstending. This is 77.61% lower than that of the IT Services sector and significantly higher than that of the Information Technology industry. The shares outstanding for all United States stocks is 92.93% higher than that of the company.
FSD Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FSD Pharma's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FSD Pharma could also be used in its relative valuation, which is a method of valuing FSD Pharma by comparing valuation metrics of similar companies.FSD Pharma is currently under evaluation in shares outstanding category among related companies.
FSD Pharma Current Valuation Drivers
We derive many important indicators used in calculating different scores of FSD Pharma from analyzing FSD Pharma's financial statements. These drivers represent accounts that assess FSD Pharma's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of FSD Pharma's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 50.0M | 18.8M | 35.6M | 30.5M | 36.4M | 34.6M | |
| Enterprise Value | 45.6M | 1.8M | 940.4K | 14.1M | 34.0M | 32.3M |
FSD Fundamentals
| Return On Equity | -0.84 | |||
| Return On Asset | -0.43 | |||
| Current Valuation | 17.48 M | |||
| Shares Outstanding | 40.43 M | |||
| Shares Owned By Insiders | 17.36 % | |||
| Shares Owned By Institutions | 2.53 % | |||
| Number Of Shares Shorted | 333.37 K | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 1.82 X | |||
| Price To Sales | 105.03 X | |||
| Gross Profit | (3.33 M) | |||
| EBITDA | (17.38 M) | |||
| Net Income | (18.56 M) | |||
| Cash And Equivalents | 31.62 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 337.46 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 3.98 X | |||
| Book Value Per Share | 0.34 X | |||
| Cash Flow From Operations | (11.03 M) | |||
| Short Ratio | 1.35 X | |||
| Earnings Per Share | (0.46) X | |||
| Target Price | 6.0 | |||
| Beta | 0.91 | |||
| Market Capitalization | 20.21 M | |||
| Total Asset | 17.39 M | |||
| Retained Earnings | (157.1 M) | |||
| Working Capital | 6.52 M | |||
| Current Asset | 3 M | |||
| Current Liabilities | 13 M | |||
| Net Asset | 17.39 M |
About FSD Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FSD Pharma Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FSD Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FSD Pharma Class based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out FSD Pharma Piotroski F Score and FSD Pharma Altman Z Score analysis. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Quarterly Revenue Growth (0.07) | Return On Assets (0.43) | Return On Equity (0.84) |
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.